在有症状的病人中的延迟的颈动脉支架术-EuropeanJournalof.pdf

1* 1 1 1 2 2 C. Setacci, G. de Donato, E. Chisci, F. Setacci, A. Stella, G. Faggioli, B. 3 3 4 4 5 Reimers, C. Cernetti, M.J. Lopera Quijada, B. Cappi and G. Sangiorgi on behalf of the Submarine Registry Group 1. Vascular and Endovascular Surgery Unit e University of Siena, Siena, Italy, 2. Vascular Surgery Unit e University of Bologna, Bologna, Italy, 3. Cardiology Depar tment, Mirano Hospi tal, Mirano (Venice) , Italy, 4. Abbott Vascular Knoll-Ravizza SpA, Milan, Italy, and 5. Invasive Cardiology Unit, San Raff aele Scientif ic Institute, Milan, Italy TIA PAPP-A, hs-CRP, MMP-2/MMP-9, IL-6/IL- 8, TNF alpha, CD40L 200552006657 TIA n=24 42% 24-48(n = 33, 58%) 1430 100% 11 1.7% 2 TIAs 3.5% PAPP-A, hs-CR, and IL-6 30 1* 2 3 2 4 A. Rijbroek, R. Boellaard, E.M. Vriens, A.A. Lammertsma and J.A. Rauwerda 1. Department of General Surgery, Kennemer Gasthuis, Haarlem, The Netherlands, 2. Department of Nuclear Medicine PET Research, Dep artments of 3. Neurology, and 4General Surgery, Vascular Surgical Unit, VU University Medical Centre, Amsterdam, The Netherlands (SP) (TCD) (EEG) (CEA)(PET) 10PET PET CBF ,OEF ,(CMRO2) (CBV) MVTT CPP MCA ,SP,SP40mmHg TCD,EEG PET CBFMVTTTCD CPP,CMRO2 PET M. Ålund, K. Mani and A. Wanhainen* Department of Surgical Sciences, Section of Vascular Surgery, Upp sala University Hosp ital, Upp sala, Sweden Uppsala1993 199320059296 ≥30 mm 179 3.2, 2.0/20 2.0 p 0.00 160 0.9% 95%0.2- 1.6% 1.5%(0.0–3.2%) ≥60 4.0% 95%3.0-5.1% 7.3%(5.7–8.9%) 0%, 0%, 1.2% (0.5– 1.8%)3.1% (1.9–4 .3%) ≥60≥65 N.V. Dias,* T.A. Resch,